ConvaTec Group PLC (LON:CTEC) Given Average Recommendation of “Moderate Buy” by Brokerages

Shares of ConvaTec Group PLC (LON:CTEC) have received an average recommendation of “Moderate Buy” from the nine analysts that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month target price among brokers that have issued ratings on the stock in the last year is GBX 306.

Several research firms have weighed in on CTEC. Berenberg Bank reiterated a “buy” rating and set a GBX 340 target price on shares of ConvaTec Group in a research note on Tuesday, April 21st. Citigroup lowered their target price on shares of ConvaTec Group from GBX 250 to GBX 230 and set a “neutral” rating for the company in a research note on Monday, May 18th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 315 target price on shares of ConvaTec Group in a research note on Wednesday, April 8th. Jefferies Financial Group reiterated a “buy” rating and set a GBX 300 target price on shares of ConvaTec Group in a research note on Monday, June 8th. Finally, JPMorgan Chase & Co. lowered their target price on shares of ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating for the company in a research note on Friday, May 22nd.

ConvaTec Group Stock Down 1.3%

CTEC stock opened at GBX 208.99 on Friday. The company has a debt-to-equity ratio of 99.96, a current ratio of 1.53 and a quick ratio of 0.96. ConvaTec Group has a 1-year low of GBX 193 and a 1-year high of GBX 291. The firm has a fifty day moving average price of GBX 209.52 and a two-hundred day moving average price of GBX 224.89. The firm has a market cap of £4.08 billion, a price-to-earnings ratio of 24.30, a PEG ratio of 0.93 and a beta of 0.76.

Insider Activity at ConvaTec Group

In other news, insider Jonny Mason purchased 50,000 shares of the stock in a transaction dated Tuesday, May 26th. The stock was acquired at an average price of GBX 201 per share, for a total transaction of £100,500. Corporate insiders own 0.98% of the company’s stock.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.